• Safety of flecainide acetate compared with amiodarone hydrochloride and sotalol in patients with atrial fibrillation and stable coronary artery disease

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium

  • Colchicine after Electrocardioversion to Prevent Recurrence of Atrial Fibrillation in Adult Patients

    Not yet recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Germany

  • Study of REGN7508 versus apixaban for treating and preventing cancer-associated blood clots in adults with solid or blood cancers

    Not yet recruiting

    3 1 1 1
    Investigated drugs:
    Bulgaria Romania

  • Study of Short‑and Long‑Term Hemodynamic and Physiological Effects of Mavacamten in Patients with Obstructive Hypertrophic Cardiomyopathy

    Not yet recruiting

    3 1 1 1
    Investigated drugs:
    Sweden

  • Study of venetoclax plus rituximab in adult patients with relapsed chronic lymphocytic leukemia (CLL) in Poland

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Poland

  • Study of inhaled levodopa versus oral levodopa plus benserazide for early‑morning OFF in Parkinson’s disease patients

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark

  • Safety, tolerability and exploratory efficacy of PST-611 in patients with geographic atrophy secondary to age-related macular degeneration

    Not yet recruiting

    2 1 1
    France

  • Evaluation of PIFLUFOLASTAT (18F) PET/CT for monitoring prostate cancer recurrence in patients with favourable intermediate‑risk localized disease after focal HIFU

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    France

  • Dose optimization study of ibrutinib drug combination in adult patients with haematological diseases

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark

  • Safety and Efficacy Study of FOXP3‑T4 and Aldesleukin in Patients with IPEX Syndrome

    Not yet recruiting

    1 1 1
    Investigated drugs:
    France

powered by